首页> 外国专利> USE OF RISPERIDONE N-OXIDE AS A PRODRUG IN ORAL, PARENTERAL, RECTAL OR TRANSDERMAL TREATMENT WITH RISPERIDONE

USE OF RISPERIDONE N-OXIDE AS A PRODRUG IN ORAL, PARENTERAL, RECTAL OR TRANSDERMAL TREATMENT WITH RISPERIDONE

机译:使用利培酮一氧化氮作为前药在利培酮的口腔,腹腔,直肠或经皮治疗中

摘要

The invention relates to the use of risperidone N-oxide as a prodrug in antipsychotic treatment. The use of N-oxide type as a prodrug generates a slow conversion to the active entity, risperidone, simultaneously with an increased time of in-vivo remanence, with constant exposure at the central level and reduction of inter-individual variability generated by the genetic polymorphism of the metabolizing enzyme.
机译:本发明涉及利培酮N-氧化物作为抗精神病药治疗中的前药的用途。使用N-氧化物类型作为前药可缓慢转化为活性实体利培酮,同时增加体内残留时间,同时在中心水平持续暴露,并降低遗传因素产生的个体间变异性代谢酶的多态性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号